Bayforest Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$135K Buy
6,937
+726
+12% +$14.4K 0.13% 312
2026
Q1
$119K Buy
+6,211
New +$122K 0.13% 302
2025
Q4
Sell
-1,040
Closed -$19.4K 938
2025
Q3
$19.4K Buy
1,040
+524
+102% +$9.79K 0.01% 648
2025
Q2
$9.52K Sell
516
-10,144
-95% -$180K ﹤0.01% 634
2025
Q1
$186K Buy
10,660
+5,313
+99% +$89.6K 0.08% 402
2024
Q4
$92.6K Buy
+5,347
New +$97.6K 0.12% 329

Other funds holding SBRA

Bayforest Capital's SBRA Position: Q2 2026 in Review

Bayforest Capital increased its Sabra Healthcare REIT (SBRA) stake by 12% in Q2 2026, buying an estimated $14.4K and bringing the position to 6,937 shares worth $135K. The position accounts for 0.13% of the portfolio, ranked #312.

Bayforest Capital first reported a position in SBRA in Q4 2024 and has held it in 6 quarters since. The position peaked at $186K in Q1 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Bayforest Capital held 6,937 shares of Sabra Healthcare REIT worth $135K as of Q2 2026.
  • Bayforest Capital bought 726 Sabra Healthcare REIT shares in Q2 2026, an estimated $14.4K.
  • Sabra Healthcare REIT made up 0.13% of Bayforest Capital's portfolio in Q2 2026, its #312 holding.
  • Bayforest Capital first reported a position in Sabra Healthcare REIT in Q4 2024 and has held it in 6 quarters since.
  • Bayforest Capital's Sabra Healthcare REIT position peaked at $186K in Q1 2025.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.